Are we underestimating health-tech?
There’s tourists. And then there’s the people who live in the place year round, whether it’s snowing, raining or the sun is shining bright. These people are the lifers. When it comes to health-tech, it appears that I am one of them.
Health-tech attracted lot of the tourist types in the heady years, back in 2020 and 2021. Around 2022, as we know from Rock Health data, it all started to stall out. Funding in the space by the end of 2023 was still significant - at $10.3 billion - but that represents the lowest amount of capital invested in the space since 2019.
The venture market is down for almost every category with the exception of AI, so that’s certainly a factor. But behind-the-scenes, I am also seeing a lot of generalist tech funds moving out of health care, either officially or unofficially (usually in the form of slowly reallocating resources and talent elsewhere). I have also examples of health care funds that can’t raise or have slowed down their pace of investing so they can focus on the existing portfolio. Please don’t ask me to name names. Because I won’t. But trust me that it is happening.
`Upcoming Sessions
Live conversations with the people shaping healthcare.
AMA with Doximity CEO Jeff Tangney
Join Doximity CEO Jeff Tangney for a live Q&A on where clinicians are finding value with AI, how Doximity has evolved, and building a company from zero to IPO.
Office Hours
A live Q&A with Christina Farr and Ruth Reader, exclusively for Second Opinion Premium members. Thursday, November 19, 1:30–2:30 p.m. ET / 10:30–11:30 a.m. PT.
The Shift Left & the Impact of the Midterms on Healthcare
Democrats just took both chambers. Aneesh Chopra, Christopher Kerns and Mike Desjadon join Ruth Reader and Christina Farr live to talk through what they'll try to do on healthcare — and what's actually achievable under a Republican White House.
Is It Finally the Moment for Alternative Health Plans?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&